New combo therapy may help more liver cancer patients become eligible for transplant
NCT ID NCT07310836
First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 23 times
Summary
This study looks at whether giving a mix of local treatments (like radiation or chemo directly to the tumor) and drugs that target blood vessels and the immune system can shrink liver cancers enough for patients to qualify for a liver transplant. About 300 patients will be included, and researchers will track how many tumors shrink, how many patients get a transplant, and how long they live afterward. The goal is to find a better way to treat advanced liver cancer before transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.